<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03439241</url>
  </required_header>
  <id_info>
    <org_study_id>CP278</org_study_id>
    <nct_id>NCT03439241</nct_id>
  </id_info>
  <brief_title>Assessment of the Performance of a New Ostomy Device in Subjects Having an Ileostomy</brief_title>
  <official_title>Assessment of the Performance of a New Ostomy Device in Sub-jects Having an Ileostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose was to investigate the performance of a new ostomy device measured with a
      measuring device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2018</start_date>
  <completion_date type="Anticipated">May 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The trial starts with a baseline period. After 4 baseplate changes the subjects is randomised into two arms.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>wear time (hours)</measure>
    <time_frame>14 days</time_frame>
    <description>Wear time is recorded at each baseplate change</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ileostomy - Stoma</condition>
  <arm_group>
    <arm_group_label>Silent arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants test the new Coloplast ostomy device use the product as they usually would.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants test the tnew Coloplast ostomy device and are guided by the measuring device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast ostomy device</intervention_name>
    <description>the test product is a newly developed Coloplast ostomy device</description>
    <arm_group_label>Silent arm</arm_group_label>
    <arm_group_label>Active arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have given written informed consent and in DK: signed a letter of authority

          2. Be at least 18 years of age and have full legal capacity

          3. Have had their ileostomy for at least 3 months

          4. Can use a product with max cut size 45 mm

          5. Self-reported problems with leakage (3 x within 14 days)

          6. Be willing and suitable (determined by the investigator representative) to use the
             test product without using a paste/mouldable ring during the test period

          7. Must be able to use custom cut product

          8. Minimum change of product every third day

          9. Get a negative result of a pregnancy test for women of childbearing age (only DK)

        Exclusion Criteria:

          1. Are currently receiving or have within the past 2 months received radio-and/or
             chemotherapy (low doses chemotherapy is allowed for other indications than cancer,
             e.g. below 15 mg methotrexate for rheumatoid arthritis)

          2. Are currently receiving or have within the past month received topical steroid
             treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid
             treatment (e.g. injection, or tablet) are allowed.

          3. Are pregnant or breastfeeding

          4. Are participating in other interventional clinical investigations or have previously
             participated in this investigation Exception: Participation in other Coloplast
             in-house clinical investigations is accepted under the circumstances that the subject
             has paused the activities in the investigation and are otherwise complying with the
             inclusion and exclusion criteria of this (CP278) protocol.

          5. Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin
             (assessed by the investigator)

          6. Have known hypersensitivity towards any of the products used in the investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birte P Jakobsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lone G Juul-Pedersen</last_name>
    <phone>+45 49113259</phone>
    <email>dklgjp@coloplast.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Coloplast A/S</name>
      <address>
        <city>Humleb√¶k</city>
        <zip>3050</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>February 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2018</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

